Supplementary Table 1:
Treatment characteristics of 57 RCC.
| RAPN, n= 18 | Cryoablation, n= 39A | |
|---|---|---|
| Anesthesia, n(%) | ||
| Sedation | N/A | 37 (97.4) |
| GA | 18 (100) | 1 (2.6) |
| Type of cryoprobes | ||
| Force | N/A | 26 (68.4) |
| Rod | 2 (5.3) | |
| Pearl | 9 (23.7) | |
| Mix | 1 (2.6) | |
| Number of probes per tumor, n(%) | ||
| 2 | N/A | 12 (31.6) |
| 3 | 14 (36.8) | |
| 4 | 7 (18.4) | |
| 5 | 3 (7.9) | |
| 6 | 1 (2.6) | |
| 7 | 1 (2.6) | |
| Hydro displacement, n(%) | ||
| Yes | 27 (71.1) | |
| No | 11 (28.9) | |
| Dose, mL | ||
| Median (IQR) | N/A | 320 (280–510) |
| Mean (±SD) | 457.9 (308.9) | |
| Range | 122–1,360 | |
| Knife time, min | ||
| Median (IQR) | 175 (160–214) | 60 (49.3–83.0) |
| Mean (±SD) | 181.1 (46.3) | 68.8 (24.5) |
| Range | 79–269 | 38–138 |
| WIT, min | ||
| Median (IQR) | 17.5 (12–20) | N/A |
| Mean (±SD) | 17.3 (5.6) | |
| Range | 11–30 | |
| Blood loss, mL | ||
| Median (IQR) | 100 (100–237.5) | N/A |
| Mean (±SD) | 183.3 (158.1) | |
| Range | 0–600 | |
| Blood transfusion, n(%) | ||
| Yes | 1 (5.3) | N/A |
| No | 18 (94.3) |
RAPN: Robot-assisted partial nephrectomy, RCC: Renal cell carcinoma, GA: General anesthesia, WIT: Warm ischemia time, N/A: Not applicable, IQR: Interquartile range, SD: Standard deviation. AOne patient underwent cryoablation of two RCC